Global Opioids Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Global Opioids Drug Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Opioids Drug Product Introduction
1.2 Market by Type
1.2.1 Global Opioids Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.3 Market by Application
1.3.1 Global Opioids Drug Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Opioids Drug Market Size Estimates and Forecasts
2.1.1 Global Opioids Drug Revenue 2017-2028
2.1.2 Global Opioids Drug Sales 2017-2028
2.2 Opioids Drug Market Size by Region: 2022 Versus 2028
2.3 Opioids Drug Sales by Region (2017-2028)
2.3.1 Global Opioids Drug Sales by Region: 2017-2022
2.3.2 Global Opioids Drug Sales Forecast by Region (2023-2028)
2.3.3 Global Opioids Drug Sales Market Share by Region (2017-2028)
2.4 Opioids Drug Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Opioids Drug Revenue by Region: 2017-2022
2.4.2 Global Opioids Drug Revenue Forecast by Region (2023-2028)
2.4.3 Global Opioids Drug Revenue Market Share by Region (2017-2028)
3 Global Opioids Drug by Manufacturers
3.1 Global Top Opioids Drug Manufacturers by Sales
3.1.1 Global Opioids Drug Sales by Manufacturer (2017-2022)
3.1.2 Global Opioids Drug Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Opioids Drug Manufacturers by Revenue
3.2.1 Global Opioids Drug Revenue by Manufacturer (2017-2022)
3.2.2 Global Opioids Drug Revenue Share by Manufacturer (2017-2022)
3.3 Global Opioids Drug Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Opioids Drug Manufacturers Covered: Ranking by Revenue
3.4.2 Global Opioids Drug Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Opioids Drug Manufacturing Base Distribution, Product Type
3.5.1 Opioids Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Opioids Drug Product Type
3.5.3 Date of International Manufacturers Enter into Opioids Drug Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Teva
4.1.1 Teva Corporation Information
4.1.2 Teva Description, Business Overview
4.1.3 Teva Opioids Drug Products Offered
4.1.4 Teva Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Teva Opioids Drug Sales by Product in 2021
4.1.6 Teva Opioids Drug Sales by Application in 2021
4.1.7 Teva Opioids Drug Sales by Geographic Area in 2021
4.1.8 Teva Recent Developments
4.2 Purdue Pharma
4.2.1 Purdue Pharma Corporation Information
4.2.2 Purdue Pharma Description, Business Overview
4.2.3 Purdue Pharma Opioids Drug Products Offered
4.2.4 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Purdue Pharma Opioids Drug Sales by Product in 2021
4.2.6 Purdue Pharma Opioids Drug Sales by Application in 2021
4.2.7 Purdue Pharma Opioids Drug Sales by Geographic Area in 2021
4.2.8 Purdue Pharma Recent Developments
4.3 Mallinckrodt
4.3.1 Mallinckrodt Corporation Information
4.3.2 Mallinckrodt Description, Business Overview
4.3.3 Mallinckrodt Opioids Drug Products Offered
4.3.4 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Mallinckrodt Opioids Drug Sales by Product in 2021
4.3.6 Mallinckrodt Opioids Drug Sales by Application in 2021
4.3.7 Mallinckrodt Opioids Drug Sales by Geographic Area in 2021
4.3.8 Mallinckrodt Recent Developments
4.4 Amneal Pharma
4.4.1 Amneal Pharma Corporation Information
4.4.2 Amneal Pharma Description, Business Overview
4.4.3 Amneal Pharma Opioids Drug Products Offered
4.4.4 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Amneal Pharma Opioids Drug Sales by Product in 2021
4.4.6 Amneal Pharma Opioids Drug Sales by Application in 2021
4.4.7 Amneal Pharma Opioids Drug Sales by Geographic Area in 2021
4.4.8 Amneal Pharma Recent Developments
4.5 Collegium
4.5.1 Collegium Corporation Information
4.5.2 Collegium Description, Business Overview
4.5.3 Collegium Opioids Drug Products Offered
4.5.4 Collegium Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Collegium Opioids Drug Sales by Product in 2021
4.5.6 Collegium Opioids Drug Sales by Application in 2021
4.5.7 Collegium Opioids Drug Sales by Geographic Area in 2021
4.5.8 Collegium Recent Developments
4.6 J&J
4.6.1 J&J Corporation Information
4.6.2 J&J Description, Business Overview
4.6.3 J&J Opioids Drug Products Offered
4.6.4 J&J Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.6.5 J&J Opioids Drug Sales by Product in 2021
4.6.6 J&J Opioids Drug Sales by Application in 2021
4.6.7 J&J Opioids Drug Sales by Geographic Area in 2021
4.6.8 J&J Recent Development
4.7 Endo
4.7.1 Endo Corporation Information
4.7.2 Endo Description, Business Overview
4.7.3 Endo Opioids Drug Products Offered
4.7.4 Endo Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Endo Opioids Drug Sales by Product in 2021
4.7.6 Endo Opioids Drug Sales by Application in 2021
4.7.7 Endo Opioids Drug Sales by Geographic Area in 2021
4.7.8 Endo Recent Development
4.8 Pfizer
4.8.1 Pfizer Corporation Information
4.8.2 Pfizer Description, Business Overview
4.8.3 Pfizer Opioids Drug Products Offered
4.8.4 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Pfizer Opioids Drug Sales by Product in 2021
4.8.6 Pfizer Opioids Drug Sales by Application in 2021
4.8.7 Pfizer Opioids Drug Sales by Geographic Area in 2021
4.8.8 Pfizer Recent Development
4.9 INSYS
4.9.1 INSYS Corporation Information
4.9.2 INSYS Description, Business Overview
4.9.3 INSYS Opioids Drug Products Offered
4.9.4 INSYS Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.9.5 INSYS Opioids Drug Sales by Product in 2021
4.9.6 INSYS Opioids Drug Sales by Application in 2021
4.9.7 INSYS Opioids Drug Sales by Geographic Area in 2021
4.9.8 INSYS Recent Development
4.10 Mylan
4.10.1 Mylan Corporation Information
4.10.2 Mylan Description, Business Overview
4.10.3 Mylan Opioids Drug Products Offered
4.10.4 Mylan Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.10.5 Mylan Opioids Drug Sales by Product in 2021
4.10.6 Mylan Opioids Drug Sales by Application in 2021
4.10.7 Mylan Opioids Drug Sales by Geographic Area in 2021
4.10.8 Mylan Recent Development
4.11 Hikma
4.11.1 Hikma Corporation Information
4.11.2 Hikma Description, Business Overview
4.11.3 Hikma Opioids Drug Products Offered
4.11.4 Hikma Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.11.5 Hikma Opioids Drug Sales by Product in 2021
4.11.6 Hikma Opioids Drug Sales by Application in 2021
4.11.7 Hikma Opioids Drug Sales by Geographic Area in 2021
4.11.8 Hikma Recent Development
4.12 Egalet
4.12.1 Egalet Corporation Information
4.12.2 Egalet Description, Business Overview
4.12.3 Egalet Opioids Drug Products Offered
4.12.4 Egalet Opioids Drug Sales, Revenue and Gross Margin (2017-2022)
4.12.5 Egalet Opioids Drug Sales by Product in 2021
4.12.6 Egalet Opioids Drug Sales by Application in 2021
4.12.7 Egalet Opioids Drug Sales by Geographic Area in 2021
4.12.8 Egalet Recent Development
5 Breakdown Data by Type
5.1 Global Opioids Drug Sales by Type (2017-2028)
5.1.1 Global Opioids Drug Sales by Type (2017-2022)
5.1.2 Global Opioids Drug Sales Forecast by Type (2023-2028)
5.1.3 Global Opioids Drug Sales Market Share by Type (2017-2028)
5.2 Global Opioids Drug Revenue Forecast by Type (2017-2028)
5.2.1 Global Opioids Drug Revenue by Type (2017-2022)
5.2.2 Global Opioids Drug Revenue Forecast by Type (2023-2028)
5.2.3 Global Opioids Drug Revenue Market Share by Type (2017-2028)
5.3 Opioids Drug Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Opioids Drug Sales by Application (2017-2028)
6.1.1 Global Opioids Drug Sales by Application (2017-2022)
6.1.2 Global Opioids Drug Sales Forecast by Application (2023-2028)
6.1.3 Global Opioids Drug Sales Market Share by Application (2017-2028)
6.2 Global Opioids Drug Revenue Forecast by Application (2017-2028)
6.2.1 Global Opioids Drug Revenue by Application (2017-2022)
6.2.2 Global Opioids Drug Revenue Forecast by Application (2023-2028)
6.2.3 Global Opioids Drug Revenue Market Share by Application (2017-2028)
6.3 Opioids Drug Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Opioids Drug Market Size YoY Growth 2017-2028
7.2 North America Opioids Drug Market Facts & Figures by Country
7.2.1 North America Opioids Drug Sales by Country (2017-2028)
7.2.2 North America Opioids Drug Revenue by Country (2017-2028)
7.3 North America Opioids Drug Sales by Type
7.4 North America Opioids Drug Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Opioids Drug Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Opioids Drug Market Facts & Figures by Region
8.2.1 Asia-Pacific Opioids Drug Sales by Region (2017-2028)
8.2.2 Asia-Pacific Opioids Drug Revenue by Region (2017-2028)
8.3 Asia-Pacific Opioids Drug Sales by Type
8.4 Asia-Pacific Opioids Drug Sales by Application
9 Europe
9.1 Europe Opioids Drug Market Size YoY Growth 2017-2028
9.2 Europe Opioids Drug Market Facts & Figures by Country
9.2.1 Europe Opioids Drug Sales by Country (2017-2028)
9.2.2 Europe Opioids Drug Revenue by Country (2017-2028)
9.3 Europe Opioids Drug Sales by Type
9.4 Europe Opioids Drug Sales by Application
10 Latin America
10.1 Latin America Opioids Drug Market Size YoY Growth 2017-2028
10.2 Latin America Opioids Drug Market Facts & Figures by Country
10.2.1 Latin America Opioids Drug Sales by Country (2017-2028)
10.2.2 Latin America Opioids Drug Revenue by Country (2017-2028)
10.3 Latin America Opioids Drug Sales by Type
10.4 Latin America Opioids Drug Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Opioids Drug Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Opioids Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Opioids Drug Sales by Country (2017-2028)
11.2.2 Middle East and Africa Opioids Drug Revenue by Country (2017-2028)
11.3 Middle East and Africa Opioids Drug Sales by Type
11.4 Middle East and Africa Opioids Drug Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Opioids Drug Supply Chain Analysis
12.2 Opioids Drug Key Raw Materials and Upstream Suppliers
12.3 Opioids Drug Clients Analysis
12.4 Opioids Drug Sales Channel and Sales Model Analysis
12.4.1 Opioids Drug Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Opioids Drug Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Opioids Drug Distributors
13 Market Dynamics
13.1 Opioids Drug Industry Trends
13.2 Opioids Drug Market Drivers
13.3 Opioids Drug Market Challenges
13.4 Opioids Drug Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Opioids Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Oxycodone
Table 3. Major Manufacturers of Hydromorphone
Table 4. Major Manufacturers of Codeine
Table 5. Major Manufacturers of Fentanyl
Table 6. Global Opioids Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Opioids Drug Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 8. Global Opioids Drug Sales by Region (2017-2022) & (M Units)
Table 9. Global Opioids Drug Sales Forecast by Region (2023-2028) & (M Units)
Table 10. Global Opioids Drug Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Opioids Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 12. Global Opioids Drug Sales by Manufacturer (2017-2022) & (M Units)
Table 13. Global Opioids Drug Sales Share by Manufacturer (2017-2022)
Table 14. Opioids Drug Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 15. Opioids Drug Revenue Share by Manufacturer (2017-2022)
Table 16. Key Manufacturers Opioids Drug Price (2017-2022) & (USD/Unit)
Table 17. Ranking of Global Top Opioids Drug Manufacturers by Revenue (US$ Million) in 2021
Table 18. Global Opioids Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 19. Global Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Opioids Drug as of 2021)
Table 20. Opioids Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Opioids Drug Product Type
Table 22. Date of International Manufacturers Enter into Opioids Drug Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Teva Corporation Information
Table 25. Teva Description and Business Overview
Table 26. Teva Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 27. Teva Opioids Drug Product
Table 28. Teva Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 29. Teva Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 30. Teva Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 31. Teva Recent Development
Table 32. Purdue Pharma Corporation Information
Table 33. Purdue Pharma Description and Business Overview
Table 34. Purdue Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 35. Purdue Pharma Opioids Drug Product
Table 36. Purdue Pharma Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 37. Purdue Pharma Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 38. Purdue Pharma Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 39. Purdue Pharma Recent Development
Table 40. Mallinckrodt Corporation Information
Table 41. Mallinckrodt Description and Business Overview
Table 42. Mallinckrodt Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 43. Mallinckrodt Opioids Drug Product
Table 44. Mallinckrodt Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 45. Mallinckrodt Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 46. Mallinckrodt Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 47. Mallinckrodt Recent Development
Table 48. Amneal Pharma Corporation Information
Table 49. Amneal Pharma Description and Business Overview
Table 50. Amneal Pharma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 51. Amneal Pharma Opioids Drug Product
Table 52. Amneal Pharma Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 53. Amneal Pharma Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 54. Amneal Pharma Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 55. Amneal Pharma Recent Development
Table 56. Collegium Corporation Information
Table 57. Collegium Description and Business Overview
Table 58. Collegium Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Collegium Opioids Drug Product
Table 60. Collegium Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 61. Collegium Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 62. Collegium Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 63. Collegium Recent Development
Table 64. J&J Corporation Information
Table 65. J&J Description and Business Overview
Table 66. J&J Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. J&J Opioids Drug Product
Table 68. J&J Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 69. J&J Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 70. J&J Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 71. Endo Corporation Information
Table 72. Endo Description and Business Overview
Table 73. Endo Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 74. Endo Opioids Drug Product
Table 75. Endo Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 76. Endo Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 77. Endo Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 78. Pfizer Corporation Information
Table 79. Pfizer Description and Business Overview
Table 80. Pfizer Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 81. Pfizer Opioids Drug Product
Table 82. Pfizer Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 83. Pfizer Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 84. Pfizer Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 85. INSYS Corporation Information
Table 86. INSYS Description and Business Overview
Table 87. INSYS Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 88. INSYS Opioids Drug Product
Table 89. INSYS Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 90. INSYS Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 91. INSYS Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 92. Mylan Corporation Information
Table 93. Mylan Description and Business Overview
Table 94. Mylan Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 95. Mylan Opioids Drug Product
Table 96. Mylan Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 97. Mylan Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 98. Mylan Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 99. Hikma Corporation Information
Table 100. Hikma Description and Business Overview
Table 101. Hikma Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Hikma Opioids Drug Product
Table 103. Hikma Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 104. Hikma Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 105. Hikma Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 106. Egalet Corporation Information
Table 107. Egalet Description and Business Overview
Table 108. Egalet Opioids Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Egalet Opioids Drug Product
Table 110. Egalet Opioids Drug Sales Proportion of Opioids Drug by Product in 2021
Table 111. Egalet Opioids Drug Sales Proportion of Opioids Drug by Application in 2021
Table 112. Egalet Opioids Drug Sales Proportion of Opioids Drug by Geographic Area in 2021
Table 113. Global Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 114. Global Opioids Drug Sales Forecast by Type (2023-2028) & (M Units)
Table 115. Global Opioids Drug Revenue by Type (2017-2022) & (US$ Million)
Table 116. Global Opioids Drug Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 117. Global Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 118. Global Opioids Drug Sales Forecast by Application (2023-2028) & (M Units)
Table 119. Global Opioids Drug Revenue by Application (2017-2022) & (US$ Million)
Table 120. Global Opioids Drug Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 121. North America Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 122. North America Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 123. North America Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 124. North America Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 125. North America Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 126. North America Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 127. Asia-Pacific Opioids Drug Sales by Region (2017-2022) & (M Units)
Table 128. Asia-Pacific Opioids Drug Sales by Region (2023-2028) & (M Units)
Table 129. Asia-Pacific Opioids Drug Revenue by Region (2017-2028) & (US$ Million)
Table 130. Asia-Pacific Opioids Drug Revenue by Region (2023-2028) & (US$ Million)
Table 131. Asia-Pacific Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 132. Asia-Pacific Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 133. Europe Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 134. Europe Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 135. Europe Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 136. Europe Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 137. Europe Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 138. Europe Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 139. Latin America Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 140. Latin America Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 141. Latin America Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 142. Latin America Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 143. Latin America Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 144. Latin America Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 145. Middle East and Africa Opioids Drug Sales by Country (2017-2022) & (M Units)
Table 146. Middle East and Africa Opioids Drug Sales by Country (2023-2028) & (M Units)
Table 147. Middle East and Africa Opioids Drug Revenue by Country (2017-2022) & (US$ Million)
Table 148. Middle East and Africa Opioids Drug Revenue by Country (2023-2028) & (US$ Million)
Table 149. Middle East and Africa Opioids Drug Sales by Type (2017-2022) & (M Units)
Table 150. Middle East and Africa Opioids Drug Sales by Application (2017-2022) & (M Units)
Table 151. Opioids Drug Key Raw Materials, Industry Status and Trend
Table 152. Opioids Drug Key Raw Materials and Upstream Suppliers
Table 153. Opioids Drug Clients Status and Trend
Table 154. Opioids Drug Typical Clients
Table 155. Opioids Drug Distributors
Table 156. Opioids Drug Market Trends
Table 157. Opioids Drug Market Drivers
Table 158. Opioids Drug Market Challenges
Table 159. Opioids Drug Market Restraints
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Sales Market Share by Type in 2021 & 2028
Figure 3. Oxycodone Product Picture
Figure 4. Hydromorphone Product Picture
Figure 5. Codeine Product Picture
Figure 6. Fentanyl Product Picture
Figure 7. Global Opioids Drug Sales Market Share by Application in 2021 & 2028
Figure 8. Pain Relief Examples
Figure 9. Anesthesia Examples
Figure 10. Others Examples
Figure 11. Opioids Drug Report Years Considered
Figure 12. Global Opioids Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Opioids Drug Market Size 2017-2028 (US$ Million)
Figure 14. Global Opioids Drug Sales 2017-2028 (M Units)
Figure 15. Global Opioids Drug Market Size Market Share by Region: 2022 Versus 2028
Figure 16. Global Opioids Drug Sales Market Share Forecast by Region (2017-2028)
Figure 17. Global Opioids Drug Revenue Market Share by Region (2017-2028)
Figure 18. Global Opioids Drug Sales Share by Manufacturer in 2021
Figure 19. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Opioids Drug Sales Market Share Forecast by Type (2017-2028)
Figure 21. Global Opioids Drug Revenue Market Share Forecast by Type (2017-2028)
Figure 22. Opioids Drug Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
Figure 23. Global Opioids Drug Sales Market Share Forecast by Application (2017-2028)
Figure 24. Global Opioids Drug Revenue Market Share Forecast by Application (2017-2028)
Figure 25. Opioids Drug Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
Figure 26. North America Opioids Drug Revenue 2017-2028 (US$ Million)
Figure 27. North America Opioids Drug Sales Market Share by Type (2017-2022)
Figure 28. North America Opioids Drug Sales Market Share by Application (2017-2022)
Figure 29. Asia-Pacific Opioids Drug Revenue 2017-2028 (US$ Million)
Figure 30. Asia-Pacific Opioids Drug Sales Market Share by Region (2017-2028)
Figure 31. Asia-Pacific Opioids Drug Revenue Market Share by Region (2017-2028)
Figure 32. Asia-Pacific Opioids Drug Sales Market Share by Type (2017-2022)
Figure 33. Asia-Pacific Opioids Drug Sales Market Share by Application (2017-2022)
Figure 34. Europe Opioids Drug Revenue Growth Rate 2017-2028 (US$ Million)
Figure 35. Europe Opioids Drug Sales Market Share by Country (2017-2028)
Figure 36. Europe Opioids Drug Revenue Market Share by Country (2017-2028)
Figure 37. Europe Opioids Drug Sales Market Share by Type (2017-2022)
Figure 38. Europe Opioids Drug Sales Market Share by Application (2017-2022)
Figure 39. Latin America Opioids Drug Revenue Growth Rate 2017-2028 (US$ Million)
Figure 40. Latin America Opioids Drug Sales Market Share by Country (2017-2028)
Figure 41. Latin America Opioids Drug Revenue Market Share by Country (2017-2022)
Figure 42. Latin America Opioids Drug Sales Market Share by Type (2017-2022)
Figure 43. Latin America Opioids Drug Sales Market Share by Application (2017-2022)
Figure 44. Middle East and Africa Opioids Drug Revenue Growth Rate 2017-2028 (US$ Million)
Figure 45. Middle East and Africa Opioids Drug Sales Market Share by Country (2017-2028)
Figure 46. Middle East and Africa Opioids Drug Revenue Market Share by Country (2017-2028)
Figure 47. Middle East and Africa Opioids Drug Sales Market Share by Type (2017-2022)
Figure 48. Middle East and Africa Opioids Drug Sales Market Share by Application (2017-2022)
Figure 49. Opioids Drug Supply Chain (Upstream and Downstream Market)
Figure 50. Global Production Market Share of Opioids Drug Raw Materials by Region in 2021
Figure 51. Opioids Drug Distribution Channels
Figure 52. Global Opioids Drug Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 53. Global Opioids Drug Percentage 2017-2028: Online Sales VS Offline Sales
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pain Management Drugs Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......

Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131

According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......

Global Opioids Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115

According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......

Global Methadone Hydrochloride Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......

Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112

Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......

Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111

According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......

Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87

According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......

Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131

According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......

Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028

Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167

The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs